Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study

Published:2023-06-09 Issue:8 Volume:64 Page:1451-1457
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Vilmar Adam¹,Dehlendorff Christian²,Friis Søren³,Jäättelä Marja⁴,Tvingsholm Siri⁴,Frederiksen Henrik⁵⁶

Affiliation:

1. Department of Hematology, Zealand University Hospital, Roskilde, Denmark

2. Statistics and Data Analysis, Danish Cancer Society Research Center, Copenhagen, Denmark

3. Cancer Surveillance and Pharmacoepidemiology, Copenhagen, Denmark

4. Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark

5. Department of Hematology, Odense University Hospital, Odense, Denmark

6. Department of Clinical Research, University of Southern Demark, Odense, Denmark

Funder

European Research Council

Danish National Research Foundation

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2216324

Reference36 articles.

1. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal

2. Randomized Trial of Omeprazole or Ranitidine Versus Placebo in the Prevention of Chemotherapy-Induced Gastroduodenal Injury

3. A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole

4. Pharmacology of proton pump inhibitors

5. Inhibition of lysosomal enzyme activities by proton pump inhibitors

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration;Cancer Treatment Reviews;2024-09

2. Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials;Scientific Reports;2024-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3